Fundraising Fox

3-V Biosciences

NASDAQ: SGMT

Menlo Park, US · Delaware corporation · 2 known investors

Biotech

Founders & leadership

DM
David MottDirector
RH
Rekha HemrajaniExecutive Officer
RR
Richard RodgersDirector
GR
Gordon RingoldDirector
MP
Merdad ParseyExecutive Officer, Director
JY
James YoungDirector
RG
Robert GarlandDirector
BS
Beth SeidenbergDirector

Investors · 2

Kleiner PerkinsreportedMenlo Park · $500K – $15Mvia Beth Seidenberg · board
Westlake Village BioPartnersreportedLos Angeles · $100K – $5Mvia Beth Seidenberg · board

Reported raises · per SEC filings

Form D private placements
▶$69MraisedJan 2021 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • George KembleExecutive Officer, Director
  • Dennis HomExecutive Officer
  • Merdad ParseyDirector
  • Beth SeidenbergDirector
  • Gordon RingoldDirector
  • Jason FullerDirector
  • James YoungDirector
  • Richard RodgersDirector
  • Jinzi Jason WuDirector
Offering amount
$80M
Amount sold
$69M
First sale
Dec 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$35.2MraisedFeb 2019 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • George KembleExecutive Officer, Director
  • Xufang DuanDirector
  • Jason FullerDirector
  • Merdad ParseyDirector
  • David MottDirector
  • Beth SeidenbergDirector
  • Richard RodgersDirector
  • Gordon RingoldDirector
  • Dennis HomExecutive Officer
  • Jinzi Jason WuDirector
  • James YoungDirector
Offering amount
$42.2M
Amount sold
$35.2M
First sale
Feb 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.4MraisedJul 2016 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James YoungDirector
  • David MottDirector
  • Beth SeidenbergDirector
  • Gordon RingoldDirector
  • Jason FullerDirector
  • Merdad ParseyDirector
  • Richard RodgersDirector
  • George KembleExecutive Officer, Director
Offering amount
$12M
Amount sold
$5.4M
First sale
Jun 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14.3MraisedMar 2015 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David MottDirector
  • Rekha HemrajaniExecutive Officer
  • Beth SeidenbergDirector
  • Richard RodgersDirector
  • Gordon RingoldDirector
  • Merdad ParseyExecutive Officer, Director
  • James YoungDirector
  • Robert GarlandDirector
Offering amount
$35M
Amount sold
$14.3M
First sale
Oct 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.